BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3917512)

  • 1. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
    Modak S; Fox CL
    J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds.
    Modak SM; Sampath L; Fox CL
    J Burn Care Rehabil; 1988; 9(4):359-63. PubMed ID: 3146573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silver sulfadiazine (AgSD) resistant pseudomonas infection in experimental burn wounds.
    Modak SM; Stanford JW; Bradshaw W; Fox CL
    Panminerva Med; 1983; 25(3):181-8. PubMed ID: 6669393
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
    Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 1% silver sulfadiazine with and without 1% chlorhexidine digluconate for topical antibacterial effect in the burnt infected rat.
    Snelling CF; Roberts FJ
    J Burn Care Rehabil; 1988; 9(1):35-40. PubMed ID: 3128553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of different topical agents on pseudomonas infection of burn wound].
    Guo Z; Gao W; He L
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 Nov; 11(6):421-4. PubMed ID: 8728928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection.
    Fox CL; Rao TN; Azmeth R; Gandhi SS; Modak S
    J Burn Care Rehabil; 1990; 11(2):112-7. PubMed ID: 2335547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of silver sulfadiazine action on burn wound infections.
    Fox CL; Modak SM
    Antimicrob Agents Chemother; 1974 Jun; 5(6):582-8. PubMed ID: 15825409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological analysis of experimental burn wounds in swine during treatment with silver sulfadiazine].
    Denys A; Grzybowski A; Białek J; Horoszewicz-Małafiej A; Korczak E; Kowalska M; Małafiej E; Szydłowska T
    Med Dosw Mikrobiol; 1983; 35(2):155-62. PubMed ID: 6423917
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study of the local application of silver sulfadiazine, cefsulodin and povidone-iodine in burns].
    Kaiser W; von der Lieth H; Potel J; Heymann H
    Infection; 1984; 12(1):31-5. PubMed ID: 6706410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats.
    Lai CS; Miskell P; Gonce SJ; Alexander JW; Babcock GF
    Burns Incl Therm Inj; 1987 Jun; 13(3):181-4. PubMed ID: 3111646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound.
    Snelling CF; Roberts FJ; Germann E; Gillespie K; Coderre S; Henry D
    Burns Incl Therm Inj; 1988 Apr; 14(2):91-100. PubMed ID: 3134114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.
    Yabanoglu H; Basaran O; Aydogan C; Azap OK; Karakayali F; Moray G
    Int Surg; 2013; 98(4):416-23. PubMed ID: 24229034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
    Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
    J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of burn wound infections by pefloxacin and its silver derivative.
    Modak S; Stanford J; Friedlaender J; Fox P; Fox CL
    Burns Incl Therm Inj; 1984 Feb; 10(3):170-8. PubMed ID: 6586256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
    Fox CL; Modak SM; Stanford JW
    Surg Gynecol Obstet; 1976 Apr; 142(4):553-9. PubMed ID: 816019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns.
    Hosseini SV; Tanideh N; Kohanteb J; Ghodrati Z; Mehrabani D; Yarmohammadi H
    Int J Surg; 2007 Feb; 5(1):23-6. PubMed ID: 17386910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection in burns.
    Settle JA
    J Hosp Infect; 1985 Sep; 6 Suppl B():19-29. PubMed ID: 2865307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.